NutriBand Inc. 8-K

What Happened NutriBand Inc. (NTRB) announced in an Item 7.01 Regulation FD disclosure dated February 13, 2026, that its Board approved the immediate termination of the agreement to sell its subsidiary, Pocono Pharmaceuticals, Inc., to Earth Vision Bio Inc. The termination follows the purchaser’s failure to pay applicable late fees after missing the December 31, 2025 closing date. NutriBand received $30,000 in late fees but reports no further payments since January 21, 2026.

Key Details

• Board action: termination approved at a meeting held February 13, 2026.
• Buyer: Earth Vision Bio Inc. failed to close on the December 31, 2025 closing date.
• Payments: NutriBand received $30,000 in late fees; no additional payments received after January 21, 2026.
• Filing: disclosed under Item 7.01 (Regulation FD Disclosure) of Form 8-K.

Why It Matters The termination means NutriBand will not transfer Pocono Pharmaceuticals to the proposed buyer as described in the purchase agreement, and the company has not reported any proceeds, purchase price or changes to guidance in this filing. For investors, this could affect anticipated cash inflows or strategic plans tied to the sale; however, the 8-K does not quantify any financial impact. Shareholders should watch for subsequent filings or disclosures that detail financial effects, next steps for the subsidiary, or any dispute or recovery efforts related to the buyer’s default.